Role of IL-17A rs2275913 and IL-17F rs763780 polymorphisms in risk of cancer development: An updated meta-analysis

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Dai, Zhi Ming ^a   Zhang, Tian Song ^b   Lin, Shuai ^a   Zhang, Wang Gang ^a   Liu, Jie ^a   Cao, Xing Mei ^a   Li, Hong Bao ^c   Wang, Meng ^a   Liu, Xing Han ^a   Liu, Kang ^a   Li, Shan Li ^a   Dai, Zhi Jun ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b Department of Neurology   (China)

^c MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

IL17A PROTEIN, HUMAN; IL17F PROTEIN, HUMAN; INTERLEUKIN 17;

CAUCASIAN; GENETIC PREDISPOSITION; GENETICS; HUMAN; META ANALYSIS; NEOPLASM; ODDS RATIO; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH TUMOR;

EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERLEUKIN-17; NEOPLASMS; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; STOMACH NEOPLASMS;

EID: 84957536249     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep20439     Document Type: Article

References (50)

1. Ferlay, J. et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136, E359-386, doi: 10.1002/ijc.29210 (2015).
2. Pharoah, P. D., Dunning, A. M., Ponder, B. A. & Easton, D. F. Association studies for finding cancer-susceptibility genetic variants. Nature Reviews Cancer 4, 850-860 (2004).
3. Smyth, M. J., Cretney, E., Kershaw, M. H. & Hayakawa, Y. Cytokines in cancer immunity and immunotherapy. Immunol Rev 202, 275-293, doi: 10.1111/j.0105-2896.2004.00199.x (2004).
4. Harrington, L. E. et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 6, 1123-1132, doi: 10.1038/ni1254 (2005).
5. Iwakura, Y., Ishigame, H., Saijo, S. & Nakae, S. Functional specialization of interleukin-17 family members. Immunity 34, 149-162, doi: 10.1016/j.immuni.2011.02.012 (2011).
6. Kawaguchi, M., Adachi, M., Oda, N., Kokubu, F. & Huang, S. K. IL-17 cytokine family. J Allergy Clin Immunol 114, 1265-1273; quiz 1274, doi: 10.1016/j.jaci.2004.10.019 (2004).
7. Kirkham, B. W. et al. Synovial membrane cytokine expression is predictive of joint damage progression in rheumatoid arthritis: a two-year prospective study (the DAMAGE study cohort). Arthritis Rheum 54, 1122-1131, doi: 10.1002/art.21749 (2006).
8. Fujino, S. et al. Increased expression of interleukin 17 in inflammatory bowel disease. Gut 52, 65-70 (2003).
9. Su, X. et al. Tumor microenvironments direct the recruitment and expansion of human Th17 cells. J Immunol 184, 1630-1641, doi: 10.4049/jimmunol.0902813 (2010).
10. Song, X. & Qian, Y. IL-17 family cytokines mediated signaling in the pathogenesis of inflammatory diseases. Cell Signal 25, 2335-2347, doi: 10.1016/j.cellsig.2013.07.021 (2013).
11. Wang, L. et al. Association analysis of IL-17A and IL-17F polymorphisms in Chinese Han women with breast cancer. PLoS One 7, e34400, doi: 10.1371/journal.pone.0034400 (2012).
12. Wu, X. et al. Association between polymorphisms in interleukin-17A and interleukin-17F genes and risks of gastric cancer. Int J Cancer 127, 86-92, doi: 10.1002/ijc.25027 (2010).
13. Shibata, T., Tahara, T., Hirata, I. & Arisawa, T. Genetic polymorphism of interleukin-17A and -17F genes in gastric carcinogenesis. Hum Immunol 70, 547-551, doi: 10.1016/j.humimm.2009.04.030 (2009).
14. Omrane, I. et al. Significant association between interleukin-17A polymorphism and colorectal cancer. Tumour Biol 35, 6627-6632, doi: 10.1007/s13277-014-1890-4 (2014).
15. Zintzaras, E. & Lau, J. Synthesis of genetic association studies for pertinent gene-disease associations requires appropriate methodological and statistical approaches. J Clin Epidemiol 61, 634-645, doi: 10.1016/j.jclinepi.2007.12.011 (2008).
16. Nemati, K., Golmoghaddam, H., Hosseini, S. V., Ghaderi, A. & Doroudchi, M. Interleukin-17FT7488 allele is associated with a decreased risk of colorectal cancer and tumor progression. Gene 561, 88-94, doi: 10.1016/j.gene.2015.02.014 (2015).
17. Gao, Y. W., Xu, M., Xu, Y., Li, D. & Zhou, S. Effect of three common IL-17 single nucleotide polymorphisms on the risk of developing gastric cancer. Oncol Lett 9, 1398-1402, doi: 10.3892/ol.2014.2827 (2015).
18. Lv, Q. et al. Association between six genetic variants of IL-17A and IL-17F and cervical cancer risk: a case-control study. Tumour Biol, doi: 10.1007/s13277-015-3041-y (2015).
19. Lee, Y. C. et al. Association between interleukin 17/interleukin 17 receptor gene polymorphisms and papillary thyroid cancer in Korean population. Cytokine 71, 283-288, doi: 10.1016/j.cyto.2014.11.011 (2015).
20. Xi, X. E. et al. Interleukin-17A and interleukin-17F gene polymorphisms and hepatitis B virus-related hepatocellular carcinoma risk in a Chinese population. Med Oncol 32, 355, doi: 10.1007/s12032-014-0355-3 (2015).
21. Wang, N. et al. IL-17 gene polymorphism is associated with susceptibility to gastric cancer. Tumour Biol 35, 10025-10030, doi: 10.1007/s13277-014-2255-8 (2014).
22. Yin, J. et al. Interleukin 17A rs4711998 A>G polymorphism was associated with a decreased risk of esophageal cancer in a Chinese population. Dis Esophagus 27, 87-92, doi: 10.1111/dote.12045 (2014).
23. Li, N. et al. IL17A gene polymorphisms, serum IL-17A and IgE levels, and hepatocellular carcinoma risk in patients with chronic hepatitis B virus infection. Mol Carcinog 53, 447-457, doi: 10.1002/mc.21992 (2014).
24. Kaabachi, W. et al. Interleukin-17A and -17F genes polymorphisms in lung cancer. Cytokine 66, 23-29, doi: 10.1016/j.cyto.2013.12.012 (2014).
25. Qinghai, Z., Yanying, W., Yunfang, C., Xukui, Z. & Xiaoqiao, Z. Effect of interleukin-17A and interleukin-17F gene polymorphisms on the risk of gastric cancer in a Chinese population. Gene 537, 328-332, doi: 10.1016/j.gene.2013.11.007 (2014).
26. Zhang, X., Zheng, L. & Sun, Y. Analysis of the association of interleukin-17 gene polymorphisms with gastric cancer risk and interaction with Helicobacter pylori infection in a Chinese population. Tumour Biol 35, 1575-1580, doi: 10.1007/s13277-013-1217-x (2014).
27. Rafiei, A. et al. Polymorphism in the interleukin-17A promoter contributes to gastric cancer. World J Gastroenterol 19, 5693-5699, doi: 10.3748/wjg.v19.i34.5693 (2013).
28. Zhou, B. et al. Interleukin-17 gene polymorphisms are associated with bladder cancer in a Chinese Han population. Mol Carcinog 52, 871-878, doi: 10.1002/mc.21928 (2013).
29. Arisawa, T. et al. Genetic polymorphisms of IL17A and pri-microRNA-938, targeting IL17A 3′-UTR, influence susceptibility to gastric cancer. Hum Immunol 73, 747-752, doi: 10.1016/j.humimm.2012.04.011 (2012).
30. Quan, Y. et al. Association between IL17 polymorphisms and risk of cervical cancer in Chinese women. Clin Dev Immunol 2012, 258293, doi: 10.1155/2012/258293 (2012).
31. Wrobel, T. et al. IL-17F gene polymorphism is associated with susceptibility to acute myeloid leukemia. J Cancer Res Clin Oncol 140, 1551-1555, doi: 10.1007/s00432-014-1674-7 (2014).
32. Korn, T., Bettelli, E., Oukka, M. & Kuchroo, V. K. IL-17 and Th17 Cells. Annu Rev Immunol 27, 485-517, doi: 10.1146/annurev.immunol.021908.132710 (2009).
33. Moseley, T. A., Haudenschild, D. R., Rose, L. & Reddi, A. H. Interleukin-17 family and IL-17 receptors. Cytokine Growth Factor Rev 14, 155-174 (2003).
34. Shime, H. et al. Tumor-secreted lactic acid promotes IL-23/IL-17 proinflammatory pathway. J Immunol 180, 7175-7183 (2008).
35. Kato, T. et al. Expression of IL-17 mRNA in ovarian cancer. Biochem Biophys Res Commun 282, 735-738, doi: 10.1006/bbrc.2001.4618 (2001).
36. Chen, J. G. et al. Intratumoral expression of IL-17 and its prognostic role in gastric adenocarcinoma patients. Int J Biol Sci 7, 53-60 (2011).
37. Straus, D. S. TNFalpha and IL-17 cooperatively stimulate glucose metabolism and growth factor production in human colorectal cancer cells. Mol Cancer 12, 78, doi: 10.1186/1476-4598-12-78 (2013).
38. Liao, R. et al. High expression of IL-17 and IL-17RE associate with poor prognosis of hepatocellular carcinoma. J Exp Clin Cancer Res 32, 3, doi: 10.1186/1756-9966-32-3 (2013).
39. Lan, C. et al. High density of IL-17-producing cells is associated with improved prognosis for advanced epithelial ovarian cancer. Cell Tissue Res 352, 351-359, doi: 10.1007/s00441-013-1567-0 (2013).
40. Zhu, X. et al. IL-17 expression by breast-cancer-associated macrophages: IL-17 promotes invasiveness of breast cancer cell lines. Breast Cancer Res 10, R95, doi: 10.1186/bcr2195 (2008).
41. Liu, X. K., Lin, X. & Gaffen, S. L. Crucial role for nuclear factor of activated T cells in T cell receptor-mediated regulation of human interleukin-17. J Biol Chem 279, 52762-52771, doi: 10.1074/jbc.M405764200 (2004).
42. Niu, Y. M., Yuan, H. & Zhou, Y. Interleukin-17 gene polymorphisms contribute to cancer risk. Mediators Inflamm 2014, 128490, doi: 10.1155/2014/128490 (2014).
43. Zhao, H. Y., Wang, R. & Ma, W. IL-17A G197A and IL-17F T7488C polymorphisms and cancer risk in Asian populations: a meta-analysis. J BUON 19, 562-566 (2014).
44. Long, Z. W. et al. Association of IL-17 polymorphisms with gastric cancer risk in Asian populations. World J Gastroenterol 21, 5707-5718, doi: 10.3748/wjg.v21.i18.5707 (2015).
45. Yao, F. et al. Role of IL-17F T7488C polymorphism in carcinogenesis: a meta-analysis. Tumour Biol 35, 9061-9068, doi: 10.1007/s13277-014-2171-y (2014).
46. Chen, X. J., Zhou, T. Y., Chen, M. & Pu, D. Meta analysis of association of the IL-17F rs763780T>C gene polymorphism with cancer risk. Asian Pac J Cancer Prev 15, 8083-8087 (2014).
47. Omrane, I. et al. Significant association between IL23R and IL17F polymorphisms and clinical features of colorectal cancer. Immunol Lett 158, 189-194, doi: 10.1016/j.imlet.2014.01.002 (2014).
48. Stroup, D. F. et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283, 2008-2012 (2000).
49. Li, J. et al. Identification of high-quality cancer prognostic markers and metastasis network modules. Nat Commun 1, 34, doi: 10.1038/ncomms1033 (2010).
50. Higgins, J. P. T. & Thompson, S. G. Quantifying heterogeneity in a meta-analysis. Statistics in Medicine 21, 1539-1558, doi: Doi 10.1002/Sim.1186 (2002).